[1] |
Li H,Fan X,Houghton J. Tumor microenvironment:the role of the tumor stroma in cancer.J Cell Biochem, 2007, 101(4): 805-815.
|
[2] |
Liotta LA,Kohn EC.The microenvironment of the tumour-host interface.Nature, 2001, 411(6835): 375-379.
|
[3] |
Jass JR.Lymphocytic infiltration and survival in rectal cancer.J Clin Pathol, 1986, 39(6): 585-589.
|
[4] |
Chew A,Salama P,Robbshaw A, et al.SPARC, FOXP3, CD8 and CD45 correlation with disease recurrence and long-term disease-free survival in colorectal cancer.PloS one, 2001, 6(7): e22047.
|
[5] |
Chiba T,Ohtani H,Mizoi T, et al.Intraepithelial CD8+ T-cell-count becomes a prognostic factor after a longer follow-up period in human colorectal carcinoma:possible association with suppression of micrometastasis.Br J Cancer, 2004, 91(9): 1711-1717.
|
[6] |
Correale P,Rotundo MS,Botta C, et al.Tumor infiltration by T lymphocytes expressing chemokine receptor 7(CCR7)is predictive of favorable outcome in patients with advanced colorectal carcinoma.Clin Cancer Res, 2001, 18(3): 850-857.
|
[7] |
Galon J,Costes A,Sanchez-Cabo F, et al.Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.Science, 2006, 313(5795): 1960-1964.
|
[8] |
Naito Y,Saito K,Shiiba K, et al.CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer.Cancer Res, 1998, 58(16): 3491-3494.
|
[9] |
Salama P,Phillips M,Grieu F, et al.Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.J Clin Oncol, 2009, 27(2): 186-192.
|
[10] |
Sinicrope FA,Rego RL,Ansell SM, et al.Intraepithelial effector(CD3+)/regulatory(FoxP3+)T-cell ratio predicts a clinical outcome of human colon carcinoma.Gastroenterology, 2009, 137(4): 1270-1279.
|
[11] |
Liu S,Lachapelle J,Leung S, et al.CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer.Breast cancer research :BCR, 2012, 14(2): 48.
|
[12] |
Mahmoud SM,Paish EC,Powe DG, et al.Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer.J Clin Oncol, 2001, 29(15): 1949-1955.
|
[13] |
Sato E,Olson SH,Ahn J, et al.Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer.Proc Natl Acad Sci, 2005, 102(51): 18538-18543.
|
[14] |
Tomsova M,Melichar B,Sedlakova I, et al.Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma.Gynecol Oncol, 2008, 108(2): 415-420.
|
[15] |
Parmar MK,Torri V,Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints.Stat Med, 1998, 17(24): 2815-2834.
|
[16] |
Tierney JF,Stewart LA,Ghersi D, et al.Practical methods for incorporating summary time-to-event data into meta-analysis.Trials, 2007, 8: 16.
|
[17] |
Mc Shane LM,Altman DG,Sauerbrei W, et al.REporting recommendations for tumour MARKer prognostic studies(REMARK). Br J Cancer, 2005, 93(4): 387-391.
|
[18] |
Hayes DF,Bast RC,Desch CE, et al.Tumor marker utility grading system:a framework to evaluate clinical utility of tumor markers.J Natl Cancer Inst, 1966, 88(20): 1456-1466.
|
[19] |
Pagès F,Kirilovsky A,Mlecnik B, et al.In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer.J Clin Oncol, 2009, 27(35): 5944-5951.
|
[20] |
Nakano O,Sato M,Naito Y, et al.Proliferative Activity of Intratumoral CD8+ T-Lymphocytes As a Prognostic Factor in Human Renal Cell Carcinoma Clinicopathologic Demonstration of Antitumor Immunity.Cancer Res, 2001, 61(13): 5132-5136.
|
[21] |
Seo AN,Lee HJ,Kim EJ, et al.Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer.Br J Cancer, 2013, 109(10): 2705-2713.
|
[22] |
Flammiger A,Bayer F,Cirugeda‐Kühnert A, et al.Intratumoral T but not B lymphocytes are related to clinical outcome in prostate cancer.Apmis, 2012, 120(11): , 901-908.
|
[23] |
Goeppert B,Frauenschuh L,Zucknick M, et al.Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer.Br J Cancer, 2013, 109(10): 2665-2674.
|
[24] |
Gooden M,De Bock G,Leffers N, et al.The prognostic influence of tumour-infiltrating lymphocytes in cancer:a systematic review with meta-analysis.Br J Cancer, 2011, 105(1): 93-103.
|
[25] |
Kost SE,Kakal JA,Nelson BH.The prognostic value of FoxP3+ tumor-infiltrating lymphocytes in cancer:a critical review of the literature.Clin Cancer Res, 2012, 18(11): 3022-3029.
|
[26] |
Suzuki H,Chikazawa N,Tasaka T, et al.Intratumoral CD8(+)T/FOXP3(+)cell ratio is a predictive marker for survival in patients with colorectal cancer.Cancer Immunol Immunother, 2011, 59(5): 653-661.
|